Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: United Nations Development Programme
Street 1: 11-13 Chemin des Anémones
Street 2: Châtelaine
City: Geneva
Province:
Post Code: CH -1219
Country: Switzerland
Phone: +41 22 917 8288
Email: saleban.omar@undp.org
Web Site: http://www.undp.org

Focal Point Contact Information

Salutation: Mr
First Name: Saleban
Last Name: Omar
Title: Senior Programme Advisor
Email: saleban.omar@undp.org
Phone: +277 25754981

Alternate Focal Point Contact Information

Salutation: Ms
First Name: Karen
Last Name: De Meritens
Title:  
Email: karen.de.meritens@undp.org
Phone: +41 22 917 8545

General Information

Organization Type - Primary: Multilateral Organization
Organization Type - Secondary: None
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
UNDP is the United Nations' global development network, an organization advocating for change and connecting countries to knowledge, experience and resources to help people build a better life. We are on the ground in 177 countries, working with them on their own solutions to global and national development challenges. Our focus is helping countries build and share solutions to the challenges of Democratic Governance, Poverty Reduction, Crisis Prevention & Recovery, Environment & Energy and HIV/AIDS.

UNDP is working with a broad range of partners to help create coalitions for change to support achievement of the Millennium Development Goals,at global, regional and national levels, to benchmark progress towards them, and to help countries to build the institutional capacity, policies and programmes to achieve the MDGs, including the MDG to promote the goal to combat HIV/AIDS, malaria and other diseases including tuberculosis.

Within the context of UNDP's partnership with the Global Fund to Fight AIDS, Tuberculosis and Malaria, UNDP is directly supporting implementation of TB grants as the Principal Recipient of Last Resort in a number of countries across all regions.

In addition UNDP is working on addressing social determinants of health, including TB. TB has often been described as a disease of poverty. Despite the enormous success of DOTS in treating and caring for those infected with TB, DOTS on its own is unlikely to achieve sustained, effective TB control globally. Combination approaches that simultaneously address the social and the biomedical dimensions of TB are urgently needed. In collaboration with a variety of partners, including WHO’s StopTB programme, UNDP is exploring such combination approaches, leveraging its experience in supporting action on the social determinants of HIV. Specifically, UNDP is exploring the ways in which emerging work in HIV-sensitive social protection might be translated to address the underlying socio-economic drivers of TB.

UNDP is also working to promo
 
Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 51 - 99
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
 
What is your organization's annual budget (USD) dedicated to TB? >$10 MIL
How did you hear about the Stop TB Partnership: Involvement in TB control provision
Why do you wish join the Stop TB Partnership: Other (please explain)
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
Within the context of UNDP's partnership with the Global Fund to Fight AIDS, Tuberculosis and Malaria, UNDP is directly supporting implementation of TB grants as the Principal Recipient of Last Resort in a number of countries across all regions. UNDP is currently Principal Recipient of Last Resort for Global Fund grants in 30 different countries covering implementation of all three diseases.

In addition UNDP is working on addressing social determinants of health, including TB. TB has often been described as a disease of poverty. Despite the enormous success of DOTS in treating and caring for those infected with TB, DOTS on its own is unlikely to achieve sustained, effective TB control globally. Combination approaches that simultaneously address the social and the biomedical dimensions of TB are urgently needed. In collaboration with a variety of partners, including WHO’s StopTB programme, UNDP is exploring such combination approaches, leveraging its experience in supporting action on the social determinants of HIV. Specifically, UNDP is exploring the ways in which emerging work in HIV-sensitive social protection might be translated to address the underlying socio-economic drivers of TB.

UNDP is also working to promote and protect human rights for people living with HIV and AIDS and Tuberculosis.

 

Geographical Reach

Which country is your headquarters located in: United States of America
Which WHO region is the main focus of your work: Global
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Belarus
Bolivia
Bosnia and Herzegovina
Cuba
El Salvador
Haiti
Iran (Islamic Republic of)
Iraq
Kyrgyzstan
Liberia
Republic of Montenegro
Sao Tome and Principe
Sudan
Syrian Arab Republic
Tajikistan
Togo
Turkmenistan
Zambia
Zimbabwe

Specializations

Advocacy, communication and social mobilization
Provision of TB products
Research and Development
TB Healthcare Services
Technical Assistance

Specializations in Countries

Advocacy, communication and social mobilization Belarus
Advocacy, communication and social mobilization Bolivia
Advocacy, communication and social mobilization Bosnia and Herzegovina
Advocacy, communication and social mobilization Cuba
Advocacy, communication and social mobilization El Salvador
Advocacy, communication and social mobilization Haiti
Advocacy, communication and social mobilization Iran (Islamic Republic of)
Advocacy, communication and social mobilization Iraq
Advocacy, communication and social mobilization Kyrgyzstan
Advocacy, communication and social mobilization Liberia
Advocacy, communication and social mobilization Republic of Montenegro
Advocacy, communication and social mobilization Sao Tome and Principe
Advocacy, communication and social mobilization Sudan
Advocacy, communication and social mobilization Syrian Arab Republic
Advocacy, communication and social mobilization Tajikistan
Advocacy, communication and social mobilization Togo
Advocacy, communication and social mobilization Turkmenistan
Advocacy, communication and social mobilization Zambia
Advocacy, communication and social mobilization Zimbabwe
Provision of TB products Belarus
Provision of TB products Bolivia
Provision of TB products Bosnia and Herzegovina
Provision of TB products Cuba
Provision of TB products El Salvador
Provision of TB products Haiti
Provision of TB products Iran (Islamic Republic of)
Provision of TB products Iraq
Provision of TB products Kyrgyzstan
Provision of TB products Liberia
Provision of TB products Republic of Montenegro
Provision of TB products Sao Tome and Principe
Provision of TB products Sudan
Provision of TB products Syrian Arab Republic
Provision of TB products Tajikistan
Provision of TB products Togo
Provision of TB products Turkmenistan
Provision of TB products Zambia
Provision of TB products Zimbabwe
Research and Development Belarus
Research and Development Bolivia
Research and Development Bosnia and Herzegovina
Research and Development Cuba
Research and Development El Salvador
Research and Development Haiti
Research and Development Iran (Islamic Republic of)
Research and Development Iraq
Research and Development Kyrgyzstan
Research and Development Liberia
Research and Development Republic of Montenegro
Research and Development Sao Tome and Principe
Research and Development Sudan
Research and Development Syrian Arab Republic
Research and Development Tajikistan
Research and Development Togo
Research and Development Turkmenistan
Research and Development Zambia
Research and Development Zimbabwe
TB Healthcare Services Belarus
TB Healthcare Services Bolivia
TB Healthcare Services Bosnia and Herzegovina
TB Healthcare Services Cuba
TB Healthcare Services El Salvador
TB Healthcare Services Haiti
TB Healthcare Services Iran (Islamic Republic of)
TB Healthcare Services Iraq
TB Healthcare Services Kyrgyzstan
TB Healthcare Services Liberia
TB Healthcare Services Republic of Montenegro
TB Healthcare Services Sao Tome and Principe
TB Healthcare Services Sudan
TB Healthcare Services Syrian Arab Republic
TB Healthcare Services Tajikistan
TB Healthcare Services Togo
TB Healthcare Services Turkmenistan
TB Healthcare Services Zambia
TB Healthcare Services Zimbabwe
Technical Assistance Belarus
Technical Assistance Bolivia
Technical Assistance Bosnia and Herzegovina
Technical Assistance Cuba
Technical Assistance El Salvador
Technical Assistance Haiti
Technical Assistance Iran (Islamic Republic of)
Technical Assistance Iraq
Technical Assistance Kyrgyzstan
Technical Assistance Liberia
Technical Assistance Republic of Montenegro
Technical Assistance Sao Tome and Principe
Technical Assistance Sudan
Technical Assistance Syrian Arab Republic
Technical Assistance Tajikistan
Technical Assistance Togo
Technical Assistance Turkmenistan
Technical Assistance Zambia
Technical Assistance Zimbabwe

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

DOTS Expansion and Enhancement:
The Global Fund achieves its goals through a broad range of partnerships, of which its relationship with UNDP is a crucial component. Since 2003, the UNDP-Global Fund Partnership has focused on three interrelated objectives:
(i) Supporting implementation, with UNDP serving as temporary Principal Recipient (PR) of Global Fund grants in countries facing exceptional development challenges and/or complex emergencies [in most other countries the Principal Recipients are national entities, i.e. Ministries of Health or national Non-Governmental Organizations (NGOs)];
(ii) Developing the capacity of national entities to take over the management of Global Fund programmes as soon as circumstances permit, or to improve their performance when they are already serving as Principal Recipients; and
(iii) Strengthening policy and programme quality of Global Fund-related work, both at country and global levels, in line with UNDP’s role as a cosponsor of UNAIDS and UNDP’s core mandates in governance and capacity development.
As of 1 December 2011, UNDP is supporting implementation of TB and/or TB/HIV grants by serving as temporary PR in 21 countries/territories, with 22 active grants (2-5 year duration). These countries include Belarus, Bosnia and Herzegovina, Kyrgyzstan, Republic of Montenegro, Tajikistan, Turkmenistan, Bolivia, Cuba, El Salvador, Haiti, Iraq, Sudan, South Sudan, Syrian Arab Republic, West Bank and Gaza, Iran, Liberia, Sao Tome and Principe, Togo, Zambia and Zimbabwe and support all key interventions in TB programming including DOTS Expansion and Enhancement, Drug Resistant TB, TB-HIV, Laboratory Strengthening, Fundamental Research and Operational Research.



Drug-Resistant TB:
The Global Fund achieves its goals through a broad range of partnerships, of which its relationship with UNDP is a crucial component. Since 2003, the UNDP-Global Fund Partnership has focused on three interrelated objectives:
(i) Supporting implementation, with UNDP serving as temporary Principal Recipient (PR) of Global Fund grants in countries facing exceptional development challenges and/or complex emergencies [in most other countries the Principal Recipients are national entities, i.e. Ministries of Health or national Non-Governmental Organizations (NGOs)];
(ii) Developing the capacity of national entities to take over the management of Global Fund programmes as soon as circumstances permit, or to improve their performance when they are already serving as Principal Recipients; and
(iii) Strengthening policy and programme quality of Global Fund-related work, both at country and global levels, in line with UNDP’s role as a cosponsor of UNAIDS and UNDP’s core mandates in governance and capacity development.
As of 1 December 2011, UNDP is supporting implementation of TB and/or TB/HIV grants by serving as temporary PR in 21 countries/territories, with 22 active grants (2-5 year duration). These countries include Belarus, Bosnia and Herzegovina, Kyrgyzstan, Republic of Montenegro, Tajikistan, Turkmenistan, Bolivia, Cuba, El Salvador, Haiti, Iraq, Sudan, South Sudan, Syrian Arab Republic, West Bank and Gaza, Iran, Liberia, Sao Tome and Principe, Togo, Zambia and Zimbabwe and support all key interventions in TB programming including DOTS Expansion and Enhancement, Drug Resistant TB, TB-HIV, Laboratory Strengthening, Fundamental Research and Operational Research.



TB-HIV:
The Global Fund achieves its goals through a broad range of partnerships, of which its relationship with UNDP is a crucial component. Since 2003, the UNDP-Global Fund Partnership has focused on three interrelated objectives:
(i) Supporting implementation, with UNDP serving as temporary Principal Recipient (PR) of Global Fund grants in countries facing exceptional development challenges and/or complex emergencies [in most other countries the Principal Recipients are national entities, i.e. Ministries of Health or national Non-Governmental Organizations (NGOs)];
(ii) Developing the capacity of national entities to take over the management of Global Fund programmes as soon as circumstances permit, or to improve their performance when they are already serving as Principal Recipients; and
(iii) Strengthening policy and programme quality of Global Fund-related work, both at country and global levels, in line with UNDP’s role as a cosponsor of UNAIDS and UNDP’s core mandates in governance and capacity development.
As of 1 December 2011, UNDP is supporting implementation of TB and/or TB/HIV grants by serving as temporary PR in 21 countries/territories, with 22 active grants (2-5 year duration). These countries include Belarus, Bosnia and Herzegovina, Kyrgyzstan, Republic of Montenegro, Tajikistan, Turkmenistan, Bolivia, Cuba, El Salvador, Haiti, Iraq, Sudan, South Sudan, Syrian Arab Republic, West Bank and Gaza, Iran, Liberia, Sao Tome and Principe, Togo, Zambia and Zimbabwe and support all key interventions in TB programming including DOTS Expansion and Enhancement, Drug Resistant TB, TB-HIV, Laboratory Strengthening, Fundamental Research and Operational Research.



Laboratory Strengthening:
The Global Fund achieves its goals through a broad range of partnerships, of which its relationship with UNDP is a crucial component. Since 2003, the UNDP-Global Fund Partnership has focused on three interrelated objectives:
(i) Supporting implementation, with UNDP serving as temporary Principal Recipient (PR) of Global Fund grants in countries facing exceptional development challenges and/or complex emergencies [in most other countries the Principal Recipients are national entities, i.e. Ministries of Health or national Non-Governmental Organizations (NGOs)];
(ii) Developing the capacity of national entities to take over the management of Global Fund programmes as soon as circumstances permit, or to improve their performance when they are already serving as Principal Recipients; and
(iii) Strengthening policy and programme quality of Global Fund-related work, both at country and global levels, in line with UNDP’s role as a cosponsor of UNAIDS and UNDP’s core mandates in governance and capacity development.
As of 1 December 2011, UNDP is supporting implementation of TB and/or TB/HIV grants by serving as temporary PR in 21 countries/territories, with 22 active grants (2-5 year duration). These countries include Belarus, Bosnia and Herzegovina, Kyrgyzstan, Republic of Montenegro, Tajikistan, Turkmenistan, Bolivia, Cuba, El Salvador, Haiti, Iraq, Sudan, South Sudan, Syrian Arab Republic, West Bank and Gaza, Iran, Liberia, Sao Tome and Principe, Togo, Zambia and Zimbabwe and support all key interventions in TB programming including DOTS Expansion and Enhancement, Drug Resistant TB, TB-HIV, Laboratory Strengthening, Fundamental Research and Operational Research.



Fundamental Research:
The Global Fund achieves its goals through a broad range of partnerships, of which its relationship with UNDP is a crucial component. Since 2003, the UNDP-Global Fund Partnership has focused on three interrelated objectives:
(i) Supporting implementation, with UNDP serving as temporary Principal Recipient (PR) of Global Fund grants in countries facing exceptional development challenges and/or complex emergencies [in most other countries the Principal Recipients are national entities, i.e. Ministries of Health or national Non-Governmental Organizations (NGOs)];
(ii) Developing the capacity of national entities to take over the management of Global Fund programmes as soon as circumstances permit, or to improve their performance when they are already serving as Principal Recipients; and
(iii) Strengthening policy and programme quality of Global Fund-related work, both at country and global levels, in line with UNDP’s role as a cosponsor of UNAIDS and UNDP’s core mandates in governance and capacity development.
As of 1 December 2011, UNDP is supporting implementation of TB and/or TB/HIV grants by serving as temporary PR in 21 countries/territories, with 22 active grants (2-5 year duration). These countries include Belarus, Bosnia and Herzegovina, Kyrgyzstan, Republic of Montenegro, Tajikistan, Turkmenistan, Bolivia, Cuba, El Salvador, Haiti, Iraq, Sudan, South Sudan, Syrian Arab Republic, West Bank and Gaza, Iran, Liberia, Sao Tome and Principe, Togo, Zambia and Zimbabwe and support all key interventions in TB programming including DOTS Expansion and Enhancement, Drug Resistant TB, TB-HIV, Laboratory Strengthening, Fundamental Research and Operational Research.



Operational Research:
The Global Fund achieves its goals through a broad range of partnerships, of which its relationship with UNDP is a crucial component. Since 2003, the UNDP-Global Fund Partnership has focused on three interrelated objectives:
(i) Supporting implementation, with UNDP serving as temporary Principal Recipient (PR) of Global Fund grants in countries facing exceptional development challenges and/or complex emergencies [in most other countries the Principal Recipients are national entities, i.e. Ministries of Health or national Non-Governmental Organizations (NGOs)];
(ii) Developing the capacity of national entities to take over the management of Global Fund programmes as soon as circumstances permit, or to improve their performance when they are already serving as Principal Recipients; and
(iii) Strengthening policy and programme quality of Global Fund-related work, both at country and global levels, in line with UNDP’s role as a cosponsor of UNAIDS and UNDP’s core mandates in governance and capacity development.
As of 1 December 2011, UNDP is supporting implementation of TB and/or TB/HIV grants by serving as temporary PR in 21 countries/territories, with 22 active grants (2-5 year duration). These countries include Belarus, Bosnia and Herzegovina, Kyrgyzstan, Republic of Montenegro, Tajikistan, Turkmenistan, Bolivia, Cuba, El Salvador, Haiti, Iraq, Sudan, South Sudan, Syrian Arab Republic, West Bank and Gaza, Iran, Liberia, Sao Tome and Principe, Togo, Zambia and Zimbabwe and support all key interventions in TB programming including DOTS Expansion and Enhancement, Drug Resistant TB, TB-HIV, Laboratory Strengthening, Fundamental Research and Operational Research.



Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date: February 21, 2012
Last updated: December 3, 2012